Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-013148

CEO and CFO bought 7,000 shares at $11.10 ($77,700)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2023-04-19 Purchase +7,000 $11.10 $77,700 5,286,177 D
Open-market purchases · 7,000 sh · avg $11.10 · $77,700
Loading xslF345X04/ownership.xml…